A new therapy based on embryonic stem cells will give a new hope to people who did lose their ability to move in some accident. But that’s not all, because this therapy, developed by the Geron Corp., is the demonstration that in USA, since a few days from Obama‘s election, a new course in research – above all in stem cells research – has begun.
The Food and Drug Administration (FDA) frees the medics to inject spinal stem cells extracted from embryonic tissue in legs paralysed patients since a short time. The treatment in on experimental phase, but stem cells should stimulate damaged nerves to grow.
The goal is to re-activate the spinal marrow normal functions. Unfortunately it’s not so operative for patients paralysed sinc more than 1 or 2 weeks.
Geron’s whole work is funded by private; at present no public funding are planned in this field due to Bush‘s 2006 veto, despite the United States Congress gives the go-ahead.
The fact that FDA did not oppose to this, although it’s an indipendent organization, suggests that something is changing.
Maybe you can find something interesting in the following sponsored links:
Incoming search terms:
geron, stem cells news 2011 embryonic against paralysis geron hopes obama public funds food drug administration endorse, stem cell transplant latest research for paralysed, spinal research news september 2011, stem cell research paralysis 2011, stem cell research sep 2011, new advances embryonic stem cell, latest news on clinical spinal stem cell trials, NHS "spinal marrow", new hopes paralysis September 2011, new advances instem cell for nervrestoration for paralysis, new advances for paralysis, latest stem cell research-spinal 2011, latest stem therapy move, medical research, obama administration stem cell research, recent advances in peralasis treatment, streckfuss-bömecke esc, streckfuss-boemeke award, streckfuss-boemeke, stem cells research retinitis pigmentosa geron, spinal stem cell latest clinical trials research news august/sept 2011, STEM CELL PARALYSIS, stem cell news sep 2011, stem cell advances with paralysis, us geron stem cell paralysis, latest in geron, LATEST DRUG NEWS FOR ALS/STEM CELL, geron helps, geron great news, geron clinical trial stem cells publication, geron cell research, geron blog oct 2011, ge geron 2011, FDA news august to september 2011 in philippines, esc streckfuß bömeke, embryonic stem cells clinical trials update september 2011, embryonic stem cell paralisis, embryonic cell transplant therapy for paralysis, geron optic nerve, geron public funding, laboratory geron usa stem cell treatment, katrin streckfuss-bömeke esc, katrin streckfuß.
2 Responses to “Embryonic stem cells against paralysis; Geron hopes in Obama for public funds. Food and Drug Administration endorse it.”
Leave a Reply